Cancer Research Versailles No Abst  Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Debniak, T.
Right arrow Articles by Lubinski, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Debniak, T.
Right arrow Articles by Lubinski, J.
[Cancer Research 65, 835-839, February 1, 2005]
© 2005 American Association for Cancer Research


Molecular Biology, Pathobiology and Genetics

CDKN2A Common Variants and Their Association with Melanoma Risk: A Population-Based Study

Tadeusz Debniak1, Rodney J. Scott4, Tomasz Huzarski1, Tomasz Byrski1, Andrzej Rozmiarek5, Boguslaw Debniak6, Elzbieta Zaluga2, Romuald Maleszka2, Józef Kladny3, Bohdan Górski1, Cezary Cybulski1, Jacek Gronwald1, Grzegorz Kurzawski1 and Jan Lubinski1

Departments of 1 Genetics and Pathology, International Hereditary Cancer Center and 2 Dermatology and Venerology, Pomeranian Medical University; 3 III Department of Surgery, Pomeranian Academy of Medicine, Szczecin, Poland; 4 Discipline of Medical Genetics, Faculty of Health, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia; 5 Regional Hospital, Zielona Góra, Poland; 6 Regional Hospital, Gorzow Wielkopolski, Poland

Requests for reprints: Tadeusz Debniak, Polabska 4, 70-115 Szczecin, Poland. Phone: 48-91-4661533; Fax: 48-91-4661533; E-mail: debniak{at}wp.pl.

The population frequencies of the CDKN2A variants remain undetermined. In Poland there are three common variants of CDKN2A: an alanine to threonine substitution (A148T), Nt500c>g and Nt540c>t, which have been detected in other populations. To establish if they are associated with an increased malignant melanoma (MM) risk we did an association study based on genotyping 471 patients with MM and 1,210 random control subjects from the same Polish population. We found a significantly increased frequency of the A148T variant among patients with MM (7.0%) in comparison with the general population (2.9%). The incidence of the A148T variant remained greater in both unselected and familial melanoma subgroups. A statistically significant positive association was seen for unselected MM (odds ratio, 2.529; P = 0.0003), especially in patients diagnosed under 50 years of age (odds ratio, 3.4; P = 0.0002). The A148T carrier population (heterozygous G/A alleles) was more likely to have a relative with malignancy compared with the noncarrier population (57% versus 36%, respectively; P = 0.03). Further examination of the CDKN2A promoter sequence done in 20 melanoma patients with the A148T change (heterozygous G/A alleles) and 20 patients with MM without this alteration identified it was in linkage disequilibrium with a polymorphism in the promoter region at position P-493. We found no statistically significant overrepresentation of the Nt500c>g and the Nt540c>t polymorphisms in the Polish melanoma population. In conclusion, the A148T variant of the CDKN2A gene seems to be associated with an increased risk of development of MM. Additional studies are required to confirm whether this particular change is associated with increased risk of other nonmelanoma malignancies.

Key Words: malignant melanoma • CDKN2A • A148T variant • Nt500c>g • Nt540c>t • P-493




This article has been cited by other articles:


Home page
BloodHome page
J. Healy, H. Belanger, P. Beaulieu, M. Lariviere, D. Labuda, and D. Sinnett
Promoter SNPs in G1/S checkpoint regulators and their impact on the susceptibility to childhood leukemia
Blood, January 15, 2007; 109(2): 683 - 692.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Kaller, R. Tuominen, A. Ahmadian, V. Magnusson, S. Egyhazi, J. Hansson, and J. Lundeberg
Detection of MC1R Polymorphisms with Protease-Mediated Allele-Specific Extension as an Alternative to Direct Sequencing
Clin. Chem., December 1, 2005; 51(12): 2388 - 2391.
[Full Text] [PDF]


Home page
J. Med. Genet.Home page
T Debniak, B Gorski, T Huzarski, T Byrski, C Cybulski, A Mackiewicz, S Gozdecka-Grodecka, J Gronwald, E Kowalska, O Haus, et al.
A common variant of CDKN2A (p16) predisposes to breast cancer
J. Med. Genet., October 1, 2005; 42(10): 763 - 765.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.